BREAKING
PDS Biotechnology Corporation (PDSB) FY 2025 Earnings Recap 18 minutes ago Unicycive Therapeutics, Inc. (UNCY) Reports FY2025 Earnings 25 minutes ago USA Rare Earth, Inc. (USAR) Reports Q4 Earnings 28 minutes ago Bicara Therapeutics 2025 Financial Update 41 minutes ago PDS Biotechnology Corporation (PDSB) Reports FY2025 Earnings 55 minutes ago Neumora Therapeutics 2025 Financial Update 1 hour ago Americas Gold and Silver Corporation (USAS) Misses FY2025 EPS Estimates by 425.0% 1 hour ago CBAK Energy Technology, Inc. (CBAT) Reports FY2025 Earnings 2 hours ago Reviva Pharmaceuticals 2025 Financial Review 2 hours ago Southland Holdings, Inc. (SLND) Q4 Earnings: Misses on EPS, Revenue Recap 3 days ago PDS Biotechnology Corporation (PDSB) FY 2025 Earnings Recap 18 minutes ago Unicycive Therapeutics, Inc. (UNCY) Reports FY2025 Earnings 25 minutes ago USA Rare Earth, Inc. (USAR) Reports Q4 Earnings 28 minutes ago Bicara Therapeutics 2025 Financial Update 41 minutes ago PDS Biotechnology Corporation (PDSB) Reports FY2025 Earnings 55 minutes ago Neumora Therapeutics 2025 Financial Update 1 hour ago Americas Gold and Silver Corporation (USAS) Misses FY2025 EPS Estimates by 425.0% 1 hour ago CBAK Energy Technology, Inc. (CBAT) Reports FY2025 Earnings 2 hours ago Reviva Pharmaceuticals 2025 Financial Review 2 hours ago Southland Holdings, Inc. (SLND) Q4 Earnings: Misses on EPS, Revenue Recap 3 days ago
ADVERTISEMENT
AlphaGraphs

Earnings Summary: Highlights of Vulcan Materials Company’s Q4 FY25 report

February 17, 2026 1 min read

Vulcan Materials Company (NYSE: VMC), a leading supplier of construction aggregates and aggregates-based construction materials, reported lower earnings for the fourth quarter of fiscal 2025, despite an increase in revenues.

  • Adjusted earnings attributable to the company from continuing operations were $ 1.70 per share in Q4, vs. $2.17 per share last year
  • On a reported basis, earnings per share decreased to $1.91 in the fourth quarter from $2.23 in the same period a year earlier
  • Q4 revenues increased to $1.91 billion from $1.85 billion in the corresponding quarter of FY24
  • Operating cash flow increased 29% from last year to $1.8 billion in the fourth quarter
  • The company reported adjusted EBITDA $518 million, vs. $550 million in Q4 2024
  • Fourth-quarter aggregates shipments rose 2% YoY, benefiting from healthy public construction activity
  • For fiscal 2026, management expects to deliver between $2.4 and $2.6 billion of adjusted EBITDA
ADVERTISEMENT